Login / Signup

Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition.

Jun TianVivian WangNi WangBaharak KhadangJulien BoudreaultKhldoun BakdounesSuhad AliJean-Jacques Lebrun
Published in: Breast cancer research : BCR (2021)
Together, our study supports the establishment and use of novel COX-2 inhibitor-based combination therapies as future strategies for TNBC treatment.
Keyphrases
  • current status
  • combination therapy
  • replacement therapy
  • bioinformatics analysis